These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11813805)

  • 1. Molecular modeling and 3D-QSAR studies in 2-aziridinyl-and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives as potential antimalarial agents.
    Pandey SK; Naware NB; Trivedi P; Saxena AK
    SAR QSAR Environ Res; 2001; 12(6):547-64. PubMed ID: 11813805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR for anti-malarial activity of 2-aziridinyl and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives.
    Zahouily M; Lazar M; Elmakssoudi A; Rakik J; Elaychi S; Rayadh A
    J Mol Model; 2006 Mar; 12(4):398-405. PubMed ID: 16341716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antimalarial activity of 2-aziridinyl- and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives.
    Lin TS; Zhu LY; Xu SP; Divo AA; Sartorelli AC
    J Med Chem; 1991 May; 34(5):1634-9. PubMed ID: 2033589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR modeling for the antimalarial activity of 1,4-naphthoquinonyl derivatives as potential antimalarial agents.
    Luan F; Xu X; Cordeiro MN; Liu H; Zhang X
    Curr Comput Aided Drug Des; 2013 Mar; 9(1):95-107. PubMed ID: 23157413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIA-QSAR coupled to different regression methods for the modeling of antimalarial activities of 2-aziridinyl and 2,3-bis-(aziridinyl)-1,4-naphtoquinonyl sulfate and acylate derivatives.
    Goodarzi M; Freitas MP
    Med Chem; 2011 Nov; 7(6):645-54. PubMed ID: 22313304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemometric modeling, docking and in silico design of triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors as antimalarials.
    Ojha PK; Roy K
    Eur J Med Chem; 2010 Oct; 45(10):4645-56. PubMed ID: 20708304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore modeling of substituted 1,2,4-Trioxanes for quantitative prediction of their antimalarial activity.
    Gupta AK; Chakroborty S; Srivastava K; Puri SK; Saxena AK
    J Chem Inf Model; 2010 Aug; 50(8):1510-20. PubMed ID: 20726605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimalarial activity: a QSAR modeling using CODESSA PRO software.
    Katritzky AR; Kulshyn OV; Stoyanova-Slavova I; Dobchev DA; Kuanar M; Fara DC; Karelson M
    Bioorg Med Chem; 2006 Apr; 14(7):2333-57. PubMed ID: 16426851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2D, 3D-QSAR and molecular docking of 4(1H)-quinolones analogues with antimalarial activities.
    Jiménez Villalobos TP; Gaitán Ibarra R; Montalvo Acosta JJ
    J Mol Graph Model; 2013 Nov; 46():105-24. PubMed ID: 24185373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacophore modeling of naphthoquinone derivatives with cytotoxic activity in human promyelocytic leukemia HL-60 cell line.
    Pérez-Sacau E; Díaz-Peñate RG; Estévez-Braun A; Ravelo AG; García-Castellano JM; Pardo L; Campillo M
    J Med Chem; 2007 Feb; 50(4):696-706. PubMed ID: 17249647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship study of antimalarial indolo [2,1-b]quinazoline-6,12-diones (tryptanthrins). Three dimensional pharmacophore modeling and identification of new antimalarial candidates.
    Bhattacharjee AK; Hartell MG; Nichols DA; Hicks RP; Stanton B; van Hamont JE; Milhous WK
    Eur J Med Chem; 2004 Jan; 39(1):59-67. PubMed ID: 14987834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative structure activity relationship study of 2,4,6-trisubstituted-s-triazine derivatives as antimalarial inhibitors of Plasmodium falciparum dihydrofolate reductase.
    Ojha H; Gahlot P; Tiwari AK; Pathak M; Kakkar R
    Chem Biol Drug Des; 2011 Jan; 77(1):57-62. PubMed ID: 20958921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in quantitative structure-activity relationship models of antimalarials.
    Roy K; Ojha PK
    Expert Opin Drug Discov; 2010 Aug; 5(8):751-78. PubMed ID: 22827798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional quantitative structure-activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach.
    Parenti MD; Pacchioni S; Ferrari AM; Rastelli G
    J Med Chem; 2004 Aug; 47(17):4258-67. PubMed ID: 15293997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational modeling tools for the design of potent antimalarial bisbenzamidines: overcoming the antimalarial potential of pentamidine.
    Cruz-Monteagudo M; Borges F; Perez González M; Cordeiro MN
    Bioorg Med Chem; 2007 Aug; 15(15):5322-39. PubMed ID: 17533134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First report on exploring structural requirements of 1,2,3,4- tetrahydroacridin-9(10H)-one analogs as antimalarials using multiple QSAR approaches: descriptor-based QSAR, CoMFA-CoMSIA 3DQSAR, HQSAR and G-QSAR approaches.
    Ojha PK; Roy K
    Comb Chem High Throughput Screen; 2013 Jan; 16(1):7-21. PubMed ID: 23127758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative structure-activity relationship studies of threo-methylphenidate analogs.
    Misra M; Shi Q; Ye X; Gruszecka-Kowalik E; Bu W; Liu Z; Schweri MM; Deutsch HM; Venanzi CA
    Bioorg Med Chem; 2010 Oct; 18(20):7221-38. PubMed ID: 20846865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
    Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD; Hamza A; Liu J; Zhan CG
    J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.